Aissel Faquir, NP
Nurse Practitioner · Boca Raton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Mira Womens Health and Midwifery · 10 clinicians in this group
Hospitals listed: Memorial Hospital Miramar · Memorial Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Aissel Faquir’s office at (561) 488-1801 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial Hospital MiramarMiramar, FLAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Memorial Healthcare System, which runs 5 hospitalsPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.481, Oct 2024 – Sep 2025
- Memorial Regional HospitalHollywood, FLAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Memorial Healthcare System, which runs 5 hospitalsPatients rate it 2 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.319, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorial Hospital Miramar
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.481 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 305 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.5 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,442 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,776 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,822 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.77 (1.21 to 6.33) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.58 (0.87 to 4.28) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.9 (0 to 18.82) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.08 (1.77 to 10.39) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.45) · 1,524 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.874 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.09 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.977 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 321 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.4 · 130 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12.3 · 131 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 326 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.8 · 114 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 76 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,503 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 66% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Memorial Regional Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 7 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.319 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.31 to 2.24) · 1,143 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1 (0.71 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 134.38 (88.72 to 180.03) · 107 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.6 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 384 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 543 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 4,672 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 7,156 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.86 (2.89 to 6.84) · 1,710 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0.12 to 3.12) · 527 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.45 (0.08 to 2.82) · 1,570 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.53 (3.13 to 15.94) · 556 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.09 (1.65 to 8.52) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 395 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.11) · 6,639 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 42 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.554 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.097 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.338 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 400 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 1,238 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 39.8 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17 · 460 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2 · 334 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 700 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.4 (3.1 to 6.2) · 311 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8.4 to 13.7) · 311 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 385 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.8 to 17.3) · 292 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 304 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,584 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Drugs they prescribed that Part D paid
$7,431
Pharmacies billed $7,431 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 131) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
110 generic and 21 brand-name prescriptions · $7,431 in drug cost · 14 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 21 | $2,040 | $97 |
| Progesterone | 12 | $831 | $69 |
| Estradiol (Twice Weekly) | 12 | $601 | $50 |
| Clotrimazole-Betamethasone | 13 | $294 | $23 |
Year by year
| 2024 | 131 | 54 | 0% (0) | 16% | $7,431 |
| 2023 | 100 | 40 | 0% (0) | 14% | $4,895 |
| 2022 | 113 | 58 | None | 12% | $7,179 |
| 2021 | 73 | 50 | None | None | $4,463 |
| 2020 | 74 | 41 | None | 15% | $4,411 |
| 2019 | 34 | 17 | 0% (0) | None | $833 |
| 2018 | 30 | 11 | 0% (0) | 43% | $324 |
| 2017 | 17 | None | 0% (0) | None | $551 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Estradiol | 18 | $440 | $24 |
| Clotrimazole-Betamethasone | 11 | $204 | $19 |
2022: 1 drug
| Estradiol | 15 | $697 | $46 |
2020: 1 drug
| Fluconazole | 11 | $68 | $6 |
Money from drug and device companies
$213 in 2025
| 2025 | 6 | 8 | None | $213 |
| 2024 | 7 | 8 | None | $159 |
| 2023 | 6 | 9 | None | $259 |
| 2022 | 4 | 16 | None | $311 |
| 2021 | 6 | 22 | None | $452 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Mayne Pharma Commercial | Bijuva | $113 | 3 payments
|
| Astellas Pharma US | Veozah | $28 | 1 payment
|
| Shield Therapeutics | Accrufer | $23 | 1 payment
|
| Biogen | Zurzuvae | $17 | 1 payment
|
| Evofem Biosciences | Phexxi | $17 | 1 payment
|
| Exeltis USA | Slynd | $16 | 1 payment
|
See all 8 published payments
| Mayne Pharma Commercial | Meals · 2025-12-11 | None | $22 |
| Mayne Pharma Commercial | Meals · 2025-12-11 | None | $1 |
| Astellas Pharma US | Meals · 2025-11-13 | Veozah | $28 |
| Shield Therapeutics | Meals · 2025-08-06 | Accrufer | $23 |
| Exeltis USA | Meals · 2025-07-10 | Slynd | $16 |
| Mayne Pharma Commercial | Meals · 2025-06-19 | Bijuva | $90 |
| Biogen | Meals · 2025-03-18 | Zurzuvae | $17 |
| Evofem Biosciences | Meals · 2025-03-04 | Phexxi | $17 |
See earlier years (2024, 2023, 2022, 2021)
2024: $159
| Astellas Pharma US | Veozah | $32 | 1 payment
|
| Mayne Pharma Commercial | None | $27 | 2 payments
|
| Hologic Sales and Service | Aptima | $24 | 1 payment
|
| Evofem Biosciences | None | $22 | 1 payment
|
| Agile Therapeutics | Twirla | $20 | 1 payment
|
| Shield Therapeutics | Accrufer | $20 | 1 payment
|
| Becton Dickinson and | Bd Onclarity | $14 | 1 payment
|
2023: $259
| Mayne Pharma Commercial | Nextstellis | $96 | 1 payment
|
| Abbvie | Lo Loestrin Fe | $61 | 3 payments
|
| Hologic Sales and Service | Aptima | $57 | 2 payments
|
| Agile Therapeutics | Twirla | $17 | 1 payment
|
| Organon | Nexplanon | $14 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $13 | 1 payment
|
2022: $311
| Myovant Sciences | Myfembree | $137 | 3 payments
|
| Abbvie | Lo Loestrin Fe | $126 | 10 payments
|
| Mayne Pharma | None | $30 | 2 payments
|
| TherapeuticsMD | Annovera | $18 | 1 payment
|
2021: $452
| AbbVie | Oriahnn | $235 | 10 payments
|
| TherapeuticsMD | Annovera | $91 | 5 payments
|
| Agile Therapeutics | Twirla | $62 | 3 payments
|
| Hologic | Aptima | $27 | 2 payments
|
| Evofem Biosciences | Phexxi | $22 | 1 payment
|
| Myovant Sciences | Myfembree | $15 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 46.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Medications listed in the chartVisits where the current medication list was documented | 7%That's few of the people this applied to. | 44 |
Professional record
- NPI
- 1144772096
- Licence
- FL 9307358
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 1142 Banyan Dr, Hollywood, FL, 33021
- NPI first listed
- 2016-10-26
- NPI last updated
- 2026-05-14
- NPI record certified
- 2026-05-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4254 W Orchid Ln, Chandler, AZ, 85226 · 112 Maverick Ct, Granbury, TX, 76049 · 111 N Orange Ave Ste 800, Orlando, FL, 32801 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
This office lists an electronic records connection.